Informations:
Erreur:
ID
12215
Description
DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02487017
Lien
https://clinicaltrials.gov/show/NCT02487017
Mots-clés
Versions (1)
- 18/10/2015 18/10/2015 -
Téléchargé le
18 octobre 2015
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Hepatocellular Carcinoma NCT02487017
Eligibility Hepatocellular Carcinoma NCT02487017
- StudyEvent: Eligibility
Similar models
Eligibility Hepatocellular Carcinoma NCT02487017
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
age
Item
18-80 years old;
boolean
C0001779 (UMLS CUI [1])
hepatocellular carcinoma
Item
histologically confirmed with hepatocellular carcinoma at stage i-ii;
boolean
C2239176 (UMLS CUI [1])
Transarterial Chemoembolization
Item
patients who can accept transcatheter arterial chemoembolization ;
boolean
C3539919 (UMLS CUI [1])
life expectancy
Item
patients who have a life expectancy of at least 3 months;
boolean
C0023671 (UMLS CUI [1])
ecog performance status
Item
patients who have a child-pugh:a/b; .eastern cooperative oncology group (ecog) performance status was 0-2.
boolean
C1520224 (UMLS CUI [1])
Blood Platelets; white blood cell
Item
white blood cell ＜3 x 10^9/l,platelet count ＜75 x 10^9/l;bun and cr more than normal limits on 3.0 times ;
boolean
C0005821 (UMLS CUI [1])
C0023516 (UMLS CUI [2])
C0023516 (UMLS CUI [2])
allergy
Item
known or suspected allergy to the investigational agent or any agent given in association with this trial;
boolean
C0020517 (UMLS CUI [1])
pregnant; lactating
Item
pregnant or lactating patients;
boolean
C0549206 (UMLS CUI [1])
C2828358 (UMLS CUI [2])
C2828358 (UMLS CUI [2])
human immunodeficiency virus (hiv) infection; hepatitis c virus (hcv)
Item
known history of human immunodeficiency virus (hiv), hepatitis c virus (hcv) or treponemapallidun (tp) infection;
boolean
C0019693 (UMLS CUI [1])
C0220847 (UMLS CUI [2])
C0220847 (UMLS CUI [2])
autoimmune disease
Item
patients who are suffering from serious autoimmune disease;
boolean
C0004364 (UMLS CUI [1])
immunosuppressant
Item
patients who had used long time or are using immunosuppressant;
boolean
C0021081 (UMLS CUI [1])
infection; active
Item
patients who had active infection;
boolean
C3714514 (UMLS CUI [1])
C0205177 (UMLS CUI [2])
C0205177 (UMLS CUI [2])
cancer treatment
Item
prior use of any anti-cancer treatment in 30 days;
boolean
C0920425 (UMLS CUI [1])
clinical study
Item
now or recently will join another experimental clinical study ;
boolean
C0008972 (UMLS CUI [1])
organ; allograft
Item
history of organ allograft;
boolean
C0178784 (UMLS CUI [1])
C0040739 (UMLS CUI [2])
C0040739 (UMLS CUI [2])
Clinical Research; Disruption
Item
other situations that the researchers considered unsuitable for this study
boolean
C0008972 (UMLS CUI [1])
C0332453 (UMLS CUI [2])
C0332453 (UMLS CUI [2])